Biomarkers of sustained systemic inflammation and microvascular dysfunction associated with post-COVID-19 condition symptoms at 24 months after SARS-CoV-2-infection.
Frontiers in immunology
View this publicationFrontiers in immunology
View this publicationScience translational medicine
View this publicationJournal of leukocyte biology
View this publicationThe Journal of infectious diseases
View this publicationiScience
View this publicationLeukemia
View this publicationJournal of clinical immunology
View this publicationiScience
View this publicationiScience
View this publicationJournal of leukocyte biology
View this publication